Fidelity Asset Manager 50
-
$22,000
0.01% of portfolio
-
Q3 2025
New
Invesco Oppenheimer International Gr A
-
$37,000
0.01% of portfolio
-
Q4 2024
Added 10.86%
$78.3B
$32,000
0.01% of portfolio
501
Q1 2023
Added 167.91%
Victory Sycamore Established Value I
-
$21,000
0.01% of portfolio
-
Q2 2025
Added 0.44%
Vanguard Us Growth Investor
-
$26,000
0.01% of portfolio
-
Q4 2024
Added 4.59%
-
$52,000
0.01% of portfolio
-
Q3 2025
Added 0.36%
American Funds Tax Exempt Bond F1
-
$21,000
0.01% of portfolio
-
Q3 2025
Added 0.75%
$0
$51,000
0.01% of portfolio
1,036
Q3 2025
Added 0.58%
-
$37,000
0.01% of portfolio
-
Q4 2024
Added 5.14%
-
$33,000
0.01% of portfolio
-
Q3 2025
Added 1.84%
$269B
$21,000
0.01% of portfolio
170
Q1 2025
Added 13.33%
Fidelity Advisor Small Cap M
-
$48,000
0.01% of portfolio
-
Q4 2024
Added 16.18%
Fidelity Advisor New Insights M
-
$49,000
0.01% of portfolio
-
Q1 2025
Added 0.82%
$0
$29,000
0.01% of portfolio
275
Q2 2022
New
$119B
$26,000
0.01% of portfolio
502
Q2 2025
Reduced 7.38%
-
$62,000
0.01% of portfolio
-
Q3 2025
Reduced 1.33%
American Funds American Balanced A
-
$43,000
0.01% of portfolio
-
Q2 2025
Added 0.63%
Nuveen Core Impact Bond A
-
$21,000
0.01% of portfolio
-
Q3 2025
Added 1.0%
-
$41,000
0.01% of portfolio
-
Q3 2024
New
$51.2B
$28,000
0.01% of portfolio
829
Q3 2025
Added 3.62%
Ab Sustainable Global Thematic A
-
$28,000
0.01% of portfolio
-
Q4 2024
Added 7.65%
Gsk PLC Adr Fsponsored Adr 1 Adr Reps 2 Ord Shs
-
$51,000
0.01% of portfolio
-
Q3 2022
New
$71.2B
$49,000
0.01% of portfolio
140
Q2 2022
New
$11.7B
$36,000
0.01% of portfolio
4,485
Q3 2025
Added 0.09%
Blackrock Health Sciences Opps Inv A
-
$37,000
0.01% of portfolio
-
Q3 2025
Added 6.77%
Domini Impact Equity Investor
-
$49,000
0.01% of portfolio
-
Q3 2022
New
$55B
$41,000
0.01% of portfolio
577
Q2 2022
New
Tweedy, Browne International Value Fund
-
$25,000
0.01% of portfolio
-
Q4 2024
Added 9.67%
Vanguard Inflation Protected Secs Inv
-
$42,000
0.01% of portfolio
-
Q3 2025
Added 1.02%
Dfa Emerging Markets Value I
-
$26,000
0.01% of portfolio
-
Q3 2025
Added 1.39%
T. Rowe Price Health Sciences
-
$57,000
0.01% of portfolio
-
Q1 2025
Reduced 26.15%
Vanguard Ma Tax Exempt Inv
-
$56,000
0.01% of portfolio
-
Q3 2025
Added 0.93%
T. Rowe Price Mid Cap Growth
-
$37,000
0.01% of portfolio
-
Q1 2024
Reduced 24.9%
Columbia Contrarian Core Inst3
-
$45,000
0.01% of portfolio
-
Q3 2025
Reduced 24.72%
T. Rowe Price Tax Efficient Equity I
-
$34,000
0.01% of portfolio
-
Q3 2022
New
Artisan Small Cap Institutional
-
$40,000
0.01% of portfolio
-
Q3 2022
New
Aqr Small Cap Multi Style R6
-
$21,000
0.01% of portfolio
-
Q4 2024
Added 13.3%
Aqr Large Cap Defensive Style I
-
$29,000
0.01% of portfolio
-
Q3 2025
Reduced 20.67%
T. Rowe Price U.S. Equity Research I
-
$25,000
0.01% of portfolio
-
Q4 2024
Added 0.53%
-
$25,000
0.01% of portfolio
-
Q1 2023
New
$0
$35,000
0.01% of portfolio
121
Q1 2025
Reduced 16.55%
Dfa International Value I
-
$61,000
0.01% of portfolio
-
Q3 2025
Added 0.83%
$0
$25,000
0.01% of portfolio
508
Q3 2025
Added 0.79%
-
$62,000
0.01% of portfolio
-
Q3 2025
Reduced 39.03%
Mfs International Intrinsic Value A
-
$58,000
0.01% of portfolio
-
Q4 2024
Added 6.24%
-
$57,000
0.01% of portfolio
-
Q3 2025
Added 0.18%
-
$37,000
0.01% of portfolio
-
Q3 2025
Added 0.44%
$1.52T
$35,000
0.01% of portfolio
126
Q3 2025
Reduced 18.18%
Dodge & Cox International Stock I
-
$36,000
0.01% of portfolio
-
Q2 2025
Added 3.18%
-
$42,000
0.01% of portfolio
-
Q3 2025
Added 0.37%